Description

Tesamorelin is a synthetic peptide medication that works as a growth hormone–releasing hormone (GHRH) analog. It stimulates the pituitary gland to increase natural growth hormone production in the body, which in turn may influence metabolism and body composition.

It is primarily used in clinical settings to reduce excess abdominal fat (visceral adiposity) in certain individuals, particularly people living with HIV-associated lipodystrophy. By enhancing growth hormone activity, tesamorelin can help reduce fat accumulation around internal organs, which is linked to metabolic and cardiovascular risks.

Tesamorelin is a prescription-only treatment and must be used under medical supervision. It is not approved for general bodybuilding, anti-aging, or performance enhancement purposes, and misuse can lead to unwanted hormonal side effects or health risks.

Common considerations include potential changes in blood sugar levels, injection-site reactions, and fluid retention. Patients using tesamorelin are typically monitored regularly by healthcare professionals to ensure safety and effectiveness.